

Cancelling your registration will remove your access to the event. If you proceed, you will no longer be able to participate or access event-related materials.
Deleting your account will remove your access to the event.
Questions? ✉ NCWH2026@roseliassociates.com
The 2026 National Conference on Women’s Health is hosted by the U.S. Department of Health and Human Services, Office on Women’s Health.
Get ready to explore breakthroughs in research, prevention, diagnosis, and treatment of health conditions that affect women across the lifespan. Learn about opportunities to bridge gaps between evidence and implementation and drive cross-sector innovation to modernize patient care and promote better health.
Registration for this event is now closed. Onsite registration will not be available.
If you are registered for the conference and are a member of the media you are required to request media credentials by Tuesday, March 10 at 3 PM. Email requests to media.ncwh@hhs.gov with your full name, phone number, and ID information.
The HHS National Conference on Women’s Health is being held at the historic Omni Shoreham Hotel in Washington, DC. This iconic hotel offers a perfect blend of historic elegance and modern convenience. The hotel's prime location near the National Mall and other major attractions offers ample opportunities for exploration and enjoyment beyond the conference.
For your convenience, a block of discounted hotel rooms at the Omni Shoreham has been secured for conference attendees. Rates are available for a limited time and won't last long!
To make your hotel reservation, use the link below or call Omni Reservations at 1-800-THE-OMNI and refer to NCWH2026.
Director of the Office of Planning, Analysis and Evaluation for the Health, Health Resources and Services Administration
View Info
Hide Info
Registration and Check-In
Marisa Clifton, MD
-
-
Rachel Rubin, MD
-
-
View Info
Hide Info
Doors at 4pm. Welcome reception from 430 pm to 630 pm. There will be a Fireside chat with Stephanie Carlton, Deputy Administrator and Chief of Staff of CMS, and Heidi Overton, Deputy Assistant to the President, White House Domestic Policy Council.
Stephanie Carlton
-
-
Heidi Overton, MD, PhD
-
-
Eboni Cornish, MD
-
-
Stephanie Haridopolos, MD, DABFM
Moderator
-
-
Kristen Honey, PhD, PMP
-
-
Amy Proal, PhD
-
-
Michal Tal, PhD
-
-
ADM Brian Christine, MD
-
-
Tammy Born Huizenga, DO
-
-
Suchitra Hourigan, MD
-
-
Marty Makary, MD, MPH
-
-
Natalie Shaw, MD, MMSc
-
-
Susan Sumner, PhD
-
-
Kyle Walsh, PhD
-
-
Susan Heeren Malzoni
-
-
View Info
Hide Info
Introductory Remarks by Susan Malzoni
Nancy Brown
-
-
Ann Allen
-
-
Jay Bhattacharya, MD, PhD
-
-
Nicole Kleinstreuer, PhD
-
-
Roberta Brinton, PhD
-
-
Asima Ahmad, MD, MPH, FACOG, DABOM
-
-
Marguerite Duane, MD, MHA
-
-
Alexis Joel
Moderator
-
-
Andrea Salcedo, DO, MPH, FACOG
-
-
Tamer Seckin, MD, FACOG
-
-
Olivia Walton, MSc
-
-
Chris Mashburn
-
-
Kim Hartwig, MD
-
-
Deborah Kilday, MSN, RN
Moderator
-
-
Angela Lanning
-
-
Lindsey Meehleis, LM, CPM
-
-
Angela Stanton King
-
-
Allyson Zucker, MSc
-
-
Laura Delano
-
-
Ellen Vora, MD, ABIHM
-
-
Tess Ferm
-
-
View Info
Hide Info
Introductory Remarks by Tess Ferm
Candace Badgett, PhD
-
-
Shira Boehler, MBA
Moderator
-
-
Ella Davar, RD, CDN
-
-
Lynese Lawson, DO, ABAARM
-
-
Allison Mignone, MBA
-
-
Ann Sheehy, MD, MS
Director of the Office of Planning, Analysis and Evaluation for the Health, Health Resources and Services Administration
Director of the Office of Planning, Analysis and Evaluation for the Health, Health Resources and Services Administration
Esther Blum, MS, RD
-
-
Suzanne Fenske, MD, FACOG
-
-
Dorothy Fink, MD
-
-
Sarah Hill, PhD
-
-
Barbara Levy, MD, FACOG
-
-
Roxy Manning
Moderator
-
-
Alicia Jackson, PhD
-
-
Chris Klomp, MBA
-
-
Piraye Beim, PhD
-
-
Chris Curry, MD, PhD
-
-
Bridget K. Devoy, JD, MSc
Moderator
-
-
Linda Griffith, PhD
-
-
Kate Ryder, MSc
-
-
Emily Stein
-
-
Vonda Wright, MD, MS
-
-
With interdisciplinary collaboration at its core, the HHS National Conference on Women’s Health will feature timely sessions addressing critical issues in women’s health and opportunities to earn continuing education (CE) credits across multiple specialties. This activity will be accredited through the Interprofessional Continuing Education (IPCE) process, ensuring that the learning experience supports collaborative, team-based care. CE credit will be available across a range of professional disciplines, with final session-specific accreditation details to be shared closer to the event.
With interdisciplinary collaboration at its core, the HHS National Conference on Women’s Health will feature timely sessions addressing critical issues in women’s health and opportunities to earn continuing education (CE) credits across multiple specialties.
This activity will be accredited through the Interprofessional Continuing Education (IPCE) process, ensuring that the learning experience supports collaborative, team-based care. CE credit will be available across a range of professional disciplines, with final session-specific accreditation details to be shared closer to the event.
A showcase of stunning visuals in one place.
Tell your event story through images
Tell your event story through images
Tell your event story through images
Tell your event story through images
Tell your event story through images
Tell your event story through images
Tell your event story through images
Tell your event story through images

Join industry experts for insightful sessions and networking opportunities.

Discover career-changing opportunities with top companies at our event.

Register now and unlock exclusive access to workshops and keynotes
The HHS National Conference on Women’s Health is being held at the historic Omni Shoreham Hotel in Washington, DC. This iconic hotel offers a perfect blend of historic elegance and modern convenience. The hotel's prime location near the National Mall and other major attractions offers ample opportunities for exploration and enjoyment beyond the conference.
For your convenience, a block of discounted hotel rooms at the Omni Shoreham has been secured for conference attendees. Rates are available until February 17, 2026, or until the block sells out – whichever comes first.
To make your hotel reservation, use the link below or call Omni Reservations at 1-800-THE-OMNI and refer to NCWH2026.
Piraye Beim, PhD
Piraye Yurttas Beim, PhD is a molecular biologist, entrepreneur, and angel investor. She founded Celmatix in 2009, serving as the company’s Chief Scientist through 2021 and CEO through the 2026 acquisition of its full therapeutic pipeline by Gedeon Richter. Celmatix was among the first biotechnology companies built around the idea that the unique biology of women required its own innovation infrastructure, datasets, and drug discovery strategies, years before the term “FemTech” existed. In 2017, Celmatix was named by Fast Company as one of the Most Innovative Companies in the World.
Under Dr. Beim’s leadership, Celmatix generated foundational discoveries into the genomic drivers of female biology and reproductive health and built a pipeline of first-in-class therapeutic programs spanning fertility, endometriosis, and ovarian health. She continues to support the advancement of these programs with Richter following the transaction. Celmatix was also the sole awardee in the ovarian health Spark category of the ARPA-H Sprint for Women’s Health, for which Dr. Beim served as Principal Investigator, recognizing the company’s work to optimize and extend ovarian function across the lifespan through novel therapeutic approaches.
Dr. Beim has dedicated more than two decades to advancing women’s health science and innovation. During her PhD training at Cornell University (Weill Medical College) and Memorial Sloan Kettering Cancer Center, she worked on the front lines of the precision medicine revolution in women’s health oncology. She later completed her postdoctoral training at the University of Cambridge, focusing on the molecular biology of fertility and reproductive health.
Dr. Beim is also the co-founder and chairman of Eve’s Ark, a nonprofit initiative working to accelerate progress in women’s health by building the scientific infrastructure needed to generate, protect, and translate high-quality biological and clinical data on female health. The initiative is grounded in the belief that everyone benefits when the unique biology of half the people on Earth is fully included in science and medicine.
Dr. Beim has been widely recognized as a leader in business and entrepreneurship. She is a member of the Aspen Global Leadership Network and has been named to ELLE’s Women in Tech Power List, Inc. Magazine’s Top Female Founders, Crain’s 40 Under 40 and Notable Women in Tech, Goldman Sachs’s Most Intriguing Entrepreneurs, Fortune’s Top 15 Founders Disrupting Their Industries, and Rock Health’s Disruptive Founder of the Year. She recently served as Chair of the Endometriosis Foundation of America and sits on the board of the Center on Rural Innovation.